Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-12

Clinical Trial Update: TNFerade Biologic to Treat Locally Advanced Prostate Cancer [Phase 1]

View source ↗

Summary

This entry reports a Phase 1 clinical trial of TNFerade Biologic for locally advanced prostate cancer; the current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TNFerade Biologic (TNFerade)

Snippet

Sponsor: GenVec | Conditions: Locally Advanced Prostate Cancer | Phase 1 | Status: UNKNOWN